452 related articles for article (PubMed ID: 34397558)
1. Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression Analysis.
Tanabe T; Shida D; Boku N; Yoshida T; Tsukamoto S; Takashima A; Kanemitsu Y
Dis Colon Rectum; 2021 Sep; 64(9):1074-1082. PubMed ID: 34397558
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
[TBL] [Abstract][Full Text] [Related]
3. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
[TBL] [Abstract][Full Text] [Related]
4. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
Antunez AG; Kanters AE; Regenbogen SE
Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
[TBL] [Abstract][Full Text] [Related]
5. Association of a Preoperative Leisure-Time Physical Activity With Short- and Long-term Outcomes of Patients Undergoing Curative Resection for Stage I to III Colorectal Cancer: A Propensity Score Matching Analysis.
You JF; Hsu YJ; Chern YJ; Hung HY; Hsieh PS; Yeh CY; Chiang JM; Tsai WS
Dis Colon Rectum; 2020 Jun; 63(6):796-806. PubMed ID: 32118625
[TBL] [Abstract][Full Text] [Related]
6. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
[TBL] [Abstract][Full Text] [Related]
7. Effects of Adjuvant Therapy Compliance and Anastomotic Leakage on the Oncologic Outcomes of Patients With Rectal Cancer After Curative Resection.
Fang C; Nie P; Jing P; Zhang Y; Yang L; Yu Y; Wang C; Zhou Z
Dis Colon Rectum; 2021 Jun; 64(6):689-696. PubMed ID: 33394777
[TBL] [Abstract][Full Text] [Related]
8. Dose-Intensified Infliximab Rescue Therapy for Severe Ulcerative Colitis Does Not Reduce Short-term Colectomy Rates or Increase Postoperative Complications.
Kosaraju RS; Wong DJ; Roth EM; Cataldo TE; Fabrizio AC; Crowell KT; Feuerstein JD; Messaris E
Dis Colon Rectum; 2022 Oct; 65(10):1232-1240. PubMed ID: 35714346
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Venous Invasion Detected by Elastin Stain May Surpass Lymph Node Status in Colon Cancer.
Kim HJ; Choi GS; Seo AN; Park JS; Park SY; Cho SH; Yoon G
Dis Colon Rectum; 2021 Aug; 64(8):955-963. PubMed ID: 33938533
[TBL] [Abstract][Full Text] [Related]
10. Surgical Approach to Transverse Colon Cancer: Analysis of Current Practice and Oncological Outcomes Using the National Cancer Database.
Crippa J; Grass F; Achilli P; Behm KT; Mathis KL; Day CN; Harmsen WS; Mari GM; Larson DW
Dis Colon Rectum; 2021 Mar; 64(3):284-292. PubMed ID: 33555708
[TBL] [Abstract][Full Text] [Related]
11. Naples Prognostic Score Is a Useful Prognostic Marker in Patients With Metastatic Colorectal Cancer.
Miyamoto Y; Hiyoshi Y; Daitoku N; Okadome K; Sakamoto Y; Yamashita K; Kuroda D; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Baba H
Dis Colon Rectum; 2019 Dec; 62(12):1485-1493. PubMed ID: 31567920
[TBL] [Abstract][Full Text] [Related]
12. Is There a Role for Neoadjuvant Systemic Therapy for cT4bM0 Colon Cancer? A Propensity Score-Matched Analysis of the National Cancer Database.
Kamel MK; Shchatsko A; Keane CA; Serpa E; Al-Qudah G; Rahouma M; Nituica C; Blebea J; Marar O
Dis Colon Rectum; 2023 Nov; 66(11):1435-1448. PubMed ID: 36876973
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Characteristics of Patients With Colorectal Cancer Who Have Benign Mesenteric Lymph Node Enlargement: A Multi-institutional Cohort Study.
Huang X; Yang Y; Liu Q; Tang X; Shi J; Qu H; Chen X; Gong L; Wang S; Tang S; Wang P; Tang L; Hu D; Yin X; Guan Y; Kong D; Tian F
Dis Colon Rectum; 2022 Jun; 65(6):804-816. PubMed ID: 34759241
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Therapy in Stage II/III Rectal Cancer: A Retrospective Study in a Disparate Population and the Effect on Survival.
Gan T; Chen Q; Huerta CT; Huang B; Evers BM; Patel JA
Dis Colon Rectum; 2021 Oct; 64(10):1212-1221. PubMed ID: 34516443
[TBL] [Abstract][Full Text] [Related]
15. Favorable Survival After Screening for Young-Onset Colorectal Cancer: Benefits of Screening in Young Adults.
Takada K; Hotta K; Imai K; Ito S; Kishida Y; Ono H
Dis Colon Rectum; 2022 Aug; 65(8):996-1004. PubMed ID: 34856591
[TBL] [Abstract][Full Text] [Related]
16. Differential Survival Benefits of 5-Fluorouracil-Based Adjuvant Chemotherapy for Patients With Microsatellite-Stable Stage III Colorectal Cancer According to the Tumor Budding Status: A Retrospective Analysis.
Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Hase K; Yamamoto J; Ueno H
Dis Colon Rectum; 2019 Nov; 62(11):1316-1325. PubMed ID: 31567925
[TBL] [Abstract][Full Text] [Related]
17. Tumor Marker Trajectories and Survival Analysis in Patients With Normal Carcinoembryonic Antigen Ranges After Colorectal Cancer Resection.
Chern YJ; Hsu HY; Hsu YJ; Hsu LY; Tsai WS; Liao CK; Jong BK; You JF
Dis Colon Rectum; 2024 Jan; 67(1):62-72. PubMed ID: 37594896
[TBL] [Abstract][Full Text] [Related]
18. Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer?
Kyong Shin J; Ah Park Y; Wook Huh J; Hyeon Yun S; Cheol Kim H; Yong Lee W; Hyung Kim S; Yun Ha S; Cho YB
Dis Colon Rectum; 2023 Aug; 66(8):e801-e808. PubMed ID: 35394982
[TBL] [Abstract][Full Text] [Related]
19. Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer.
Hagerty BL; Aversa JG; Dominguez DA; Davis JL; Hernandez JM; McCormick JT; Blakely AM
Dis Colon Rectum; 2022 Oct; 65(10):1206-1214. PubMed ID: 34897212
[TBL] [Abstract][Full Text] [Related]
20. Multiple High-Risk Features for Stage II Colon Carcinoma Portends Worse Survival Than Stage III Disease.
Hajirawala LN; Yi Y; Herritt BC; Laurent ME; Klinger AL; Orangio GR; Davis KG; Barton JS
Dis Colon Rectum; 2023 Aug; 66(8):1076-1084. PubMed ID: 35239528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
